How Long Does It Take for Skin Cancer to Develop?

The cellular changes that eventually lead to cancer may build over many years, particularly after repeated ultraviolet (UV) exposure. Once a cancer has formed, however, the speed at which it grows can vary considerably.

A basal cell carcinoma may change slowly over months or years. Some melanomas can also develop gradually, while others may grow and progress much more quickly.

This is why the appearance and behaviour of a skin lesion matter more than trying to estimate how long it has been there.

Skin Cancer Can Develop Gradually

Skin cancer begins when cells acquire changes that allow them to grow abnormally. UV radiation from sunlight and sunbeds is an important cause of this damage, particularly for the common forms of skin cancer.

The process can be gradual. Someone may accumulate UV-related damage over many years before a visible cancer develops. Age, skin type, previous sunburn, cumulative sun exposure, sunbed use, immune suppression and genetic factors can all influence risk.

Once skin cancer has been confirmed, the next question is how it is likely to behave and what treatment is appropriate. Different skin cancer treatment options may be considered depending on the type of cancer, its location and stage, and whether it has spread beyond the skin.

The time it took the cancer to develop is therefore only one part of a much wider clinical picture.

Different Skin Cancers Grow Differently

There is no single answer to how quickly skin cancer develops because the main types behave differently.

Basal cell carcinoma (BCC) is usually slow growing. A lesion may gradually enlarge over months or sometimes years. Although BCC rarely spreads to distant parts of the body, delaying treatment can allow it to invade more deeply into nearby tissue and make treatment more extensive.

Squamous cell carcinoma (SCC) can grow more quickly than BCC and has a greater potential to spread, although behaviour varies considerably between individual tumours.

The differences between BCC and SCC matter because the type, location and characteristics of the tumour all influence how it is managed.

Melanoma requires particular attention because some melanomas have the potential to progress more rapidly and spread beyond the skin.

Melanoma Does Not Follow One Timeline

Melanoma begins in melanocytes, the pigment-producing cells of the skin. It can develop in an existing mole, but it can also appear as a completely new lesion.

Some melanomas change gradually over months or longer. Others, particularly certain more aggressive forms such as nodular melanoma, may grow noticeably over a much shorter period.

This variability is why there is no reliable rule stating how many weeks or months a melanoma takes to develop.

The question of how fast melanoma spreads also depends on characteristics such as its subtype, depth and whether ulceration is present. Once melanoma has been removed and examined, Breslow thickness provides important information about how deeply it has grown into the skin.

A lesion does not need to have been present for a long time to deserve assessment. A new or changing lesion can be important even when the change has occurred relatively recently.

Skin Damage Can Begin Years Earlier

The visible cancer is not necessarily the beginning of the process.

Repeated UV exposure can cause DNA damage long before a suspicious lesion becomes apparent. This helps explain why skin cancer may develop later in life following substantial sun exposure or sunburn earlier in life.

It also means that preventing further UV damage remains worthwhile at any age.

Practical skin cancer prevention includes avoiding sunburn, limiting excessive UV exposure, using appropriate sun protection and avoiding sunbeds.

Reducing future exposure cannot undo every previous cellular change, but it can reduce additional UV damage.

Changes Can Matter More Than Speed

Trying to remember exactly when a lesion first appeared is not always possible. Fortunately, you do not need to know its precise age before seeking medical advice.

What often matters is whether the area is behaving differently from normal skin.

Changes that deserve assessment can include:

• A mole changing in size, shape or colour
• A new or unusual-looking skin lesion
• A sore that repeatedly crusts or bleeds
• A persistent patch that does not heal
• A lump or lesion that continues growing
• New itching, tenderness or other changes in sensation

These skin cancer symptoms do not automatically mean cancer. Many skin changes are benign.

However, a persistent or evolving lesion should be assessed appropriately rather than monitored indefinitely at home.

How Is a Suspicious Lesion Assessed?

The first step is usually assessment by a GP, dermatologist or appropriately trained skin specialist.

For suspicious pigmented lesions referred to secondary or tertiary care, NICE recommends dermoscopy by a healthcare professional trained in the technique. Depending on the findings, a lesion may then need removal or biopsy so that the tissue can be examined under a microscope.

The pathology result can establish whether cancer is present and, if so, what type.

For melanoma, details such as Breslow thickness and ulceration can help determine the stage and whether further assessment is appropriate. Treatment for early melanoma is primarily surgical, while higher-risk or advanced disease may require additional treatment.

This distinction is important because the appearance of a lesion alone cannot reliably establish how advanced a cancer is.

Treatment Depends on What Is Found

For many early skin cancers, local treatment may be sufficient.

Surgery is commonly used for BCC, SCC and early melanoma. Depending on the circumstances, other treatments may include radiotherapy, while immunotherapy and targeted therapies have important roles in selected patients with higher-risk or advanced melanoma.

The broader skin cancer treatment approach therefore depends much more on the confirmed diagnosis than on how long someone believes the lesion has been present.

This is also why two lesions that have both been noticeable for six months may require very different treatment.

Earlier Assessment Can Simplify Decisions

Skin cancers are often easier to manage when identified before they have grown extensively or spread.

This does not mean every new mole, freckle or patch of dry skin is an emergency. Most skin changes are not cancer.

It does mean that persistent or evolving changes should not be dismissed simply because they are painless, small or have been present for some time.

Melanoma is particularly important in this respect. Many melanomas are successfully treated when identified at an early stage, whereas more advanced disease can require additional systemic treatment and more complex oncology care.

If skin cancer has already been confirmed and there is uncertainty about the diagnosis, staging or recommended treatment, a second opinion can provide an independent review of the available findings and treatment plan.

There Is No Cancer Countdown

It is natural to look backwards after a skin cancer diagnosis and wonder exactly when the cancer started.

In most cases, there is no way to identify a precise date.

The biological changes leading to skin cancer may have accumulated over years, while the visible tumour may have appeared much more recently. Its subsequent growth rate can then vary according to the particular type and biology of the cancer.

For someone with a confirmed diagnosis, the more useful questions are what type of skin cancer is present, how far it has grown or spread and which treatment is appropriate now.

A private oncology consultant can help review these factors when specialist oncology input is needed following diagnosis.

About Dr James Wilson

Once melanoma or another skin cancer has been confirmed, understanding exactly what the diagnosis means can make the next treatment decisions easier to navigate.

Dr James Wilson is a consultant clinical oncologist in full-time private practice in Central London, specialising in melanoma, skin cancer and advanced radiotherapy. He takes a clear, patient-focused approach to oncology care, helping patients make sense of their diagnosis, understand the options available and feel more confident about the treatment decisions ahead.